D-743-2014 Class III Terminated
FDA drug recall D-743-2014 was initiated by Novartis Consumer Health on May 15, 2013 and is designated Class III. Reason for recall: Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing. The recall status is terminated (terminated Nov 4, 2014). Affected quantity: 3,768/8-caplet packages and 300,580/24-caplet packages.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 22, 2014
- Initiation Date
- May 15, 2013
- Termination Date
- Nov 4, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,768/8-caplet packages and 300,580/24-caplet packages
Product description
Theraflu Nighttime Warming Relief Nighttime Multi-Symptom Cold, Acetaminophen 325mg , Chlorpheniramine Maleate 2mg , Dextromethorphan HBr 10mg , Phenylephrine HCL 5mg, a) 8 coated caplets (NDC 0067-6437-08) b) 24 coated caplets (NDC 0067-6438-24). Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622.
Reason for recall
Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.
Distribution pattern
Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.
Code information
a) 08 caplets: Lot# 10121222 exp 07/13. b) 24 caplets: Lot# 10117231 exp 06/13 Lot# 10117814 exp 06/13 Lot# 10119341 exp 07/13 Lot# 10123425 exp 08/13 Lot# 10124156 exp 10/13
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-743-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026